• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Request Free Sample ×
    ReportInfographic

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    UK Helicobacter Pylori Test Market

    ID: MRFR/HC/49449-HCR
    200 Pages
    Rahul Gotadki
    September 2025

    UK Helicobacter Pylori Test Market Research Report By Type (Non-endoscopic, Endoscopic), By Technology (Immunoassays, Point of care, Molecular Diagnostics) and By End User (Hospitals & clinics, Diagnostic laboratories, Others)- Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    UK Helicobacter Pylori Test Market Research Report - Forecast to 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0
    Compare License
    Summary Table of Contents Segmentation Infographic

    UK Helicobacter Pylori Test Market Summary

    The United Kingdom Helicobacter Pylori Test market is projected to grow significantly from 98.7 million USD in 2024 to 435 million USD by 2035.

    Key Market Trends & Highlights

    UK Helicobacter Pylori Test Key Trends and Highlights

    • The market is expected to witness a compound annual growth rate of 14.43 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 435 million USD, indicating robust growth potential.
    • In 2024, the market is valued at 98.7 million USD, reflecting the current demand for Helicobacter Pylori testing.
    • Growing adoption of advanced diagnostic technologies due to increasing awareness of gastrointestinal health is a major market driver.

    Market Size & Forecast

    2024 Market Size 98.7 (USD Million)
    2035 Market Size 435 (USD Million)
    CAGR (2025-2035) 14.43%

    Major Players

    BioRad Laboratories, Abbott Laboratories, Thermo Fisher Scientific, DiaSorin, Cypress Diagnostics, Laboratory Corporation of America Holdings, Genometrics, BDSekisui Diagnostics, Meridian Bioscience, MediSense, Quidel Corporation, F. Hoffmann-La Roche, Hologic, AccuBioTech

    UK Helicobacter Pylori Test Market Trends

    The UK Helicobacter Pylori Test Market is experiencing notable trends driven by a few key market drivers. One significant driver is the increasing awareness about the health implications associated with Helicobacter pylori infections, such as peptic ulcers and gastric cancer. Many healthcare providers are now advocating for routine screening in at-risk populations, which enhances early diagnosis and improves treatment efficacy. Additionally, the National Health Service (NHS) guidelines recommend more comprehensive testing strategies, reinforcing the importance of H. pylori identification in the management of gastrointestinal disorders.

    Recent developments in testing methods, particularly non-invasive tests and rapid detection kits, are opportunities that can be explored further in the UK market.Innovations in technology are making tests more accessible and user-friendly, appealing to both healthcare professionals and patients. The growing shift towards telehealth solutions has also opened new avenues for remote testing and consultation, making it easier for patients to get diagnosed and treated promptly. There is a shift towards personalized medicine that tailors interventions based on individual testing outcomes, which is becoming increasingly popular in the UK healthcare landscape.

    Furthermore, as the population ages, the demand for H. pylori testing is expected to rise, given the demographic trends in the UK that show an increase in chronic health conditions associated with older age groups.Overall, the UK Helicobacter Pylori Test Market is adapting to these trends, ensuring improved healthcare outcomes and the potential for enhanced patient experiences through better diagnostic capabilities.

    Market Segment Insights

    Helicobacter Pylori Test Market Type Insights

    The UK Helicobacter Pylori Test Market is increasingly significant due to the rising incidence of Helicobacter Pylori infections, which are primarily associated with chronic gastritis and peptic ulcer disease. Within this market, the segmentation by Type plays a crucial role in determining the appropriate diagnostic methodologies utilized across the healthcare landscape. The two primary categories, which are Non-endoscopic and Endoscopic tests, show distinct operational characteristics and applicability in clinical practice. Non-endoscopic testing methods are gaining popularity, particularly due to their non-invasive nature and ease of administration, leading to wider acceptance among patients.

    These methods often include breath tests and serological testing, which do not require specialized equipment or in-hospital settings, making them an attractive option for general practitioners. Non-endoscopic tests benefit from rapid results and a simplified process, appealing especially to those seeking immediate diagnosis and treatment options, ultimately helping to control the infection rate more effectively.

    On the other hand, Endoscopic testing remains an integral part of the diagnostic process, particularly for patients exhibiting severe symptoms or requiring a direct examination of the gastrointestinal tract. This category provides detailed insight into the mucosal condition, allowing for biopsies when needed and thereby facilitating immediate treatment interventions. Although Endoscopic testing is more invasive, it is essential for accurately diagnosing complex cases, making it indispensable in the medical toolkit.

    As the healthcare infrastructure in the UK continues to evolve, the ability to offer both Non-endoscopic and Endoscopic testing caters to a broader range of patient needs and preferences, enhancing overall healthcare delivery.

    Moreover, advancements in technology are driving innovations in both segments, improving the accuracy and speed of diagnostics. Increased focus on identifying Helicobacter Pylori infections has been supported by public health campaigns highlighting the importance of early detection and treatment in reducing gastric cancer risks, propelling both testing methods' utilization. Overall, the segmentation of the UK Helicobacter Pylori Test Market into Non-endoscopic and Endoscopic categories underscores a comprehensive approach to managing and diagnosing this common yet significant gastrointestinal infection.

    Helicobacter Pylori Test Market Technology Insights

    The Technology segment of the UK Helicobacter Pylori Test Market plays a crucial role in advancing testing methodologies to detect Helicobacter Pylori infections, which are linked to various gastrointestinal disorders. Within this segment, Immunoassays are significant due to their ability to provide accurate results in laboratory settings, facilitating effective treatment plans. Point of care testing is becoming increasingly essential, allowing for real-time diagnosis and immediate therapeutic decisions, especially in remote areas or situations where immediate results are paramount.Molecular Diagnostics technology has gained traction as it offers higher sensitivity and specificity, making it vital for precise identification of H.

    Pylori and determining antibiotic resistance. The growing need for efficient diagnostics driven by rising infection rates and increasing public awareness contributing to the expansion of these technologies. Each aspect of this segment contributes uniquely to the overall market by improving patient outcomes and treatment efficacy, indicating substantial growth potential in the coming years. As the UK continues to prioritize health advancements, the Technology segment will be central in evolving diagnostic landscapes.

    Helicobacter Pylori Test Market End User Insights

    The UK Helicobacter Pylori Test Market demonstrates significant growth potential, particularly within the End User segment, which comprises key areas such as Hospitals and clinics, Diagnostic laboratories, and Others. Hospitals and clinics play a crucial role in diagnosing and managing Helicobacter Pylori infections, thus contributing substantially to the overall market dynamics as they often serve as the primary point of care for patients. Diagnostic laboratories are also critical, as they provide specialized testing services, ensuring accurate results that guide treatment decisions.This reliance on diagnostic accuracy drives innovation and technological advancements, fostering a competitive environment.

    Additionally, Other facilities, including outpatient centers and home testing services, complement traditional healthcare settings by offering increased accessibility and convenience for patients. With the rising prevalence of gastric disorders in the UK, the market is poised for sustained growth, driven by increasing awareness of H. Pylori health risks, advancements in testing technologies, and a greater emphasis on preventive healthcare measures.As such, the segmentation within the ser category reflects a diversified approach to addressing the healthcare needs associated with Helicobacter Pylori infections in the UK.

    Get more detailed insights about UK Helicobacter Pylori Test Market Research Report - Forecast to 2035

    Request Free Sample

    Key Players and Competitive Insights

    The UK Helicobacter Pylori Test Market is characterized by a dynamic competitive landscape, reflecting a growing emphasis on gastrointestinal health and the rising prevalence of Helicobacter Pylori infections among the population. As awareness of the health implications tied to these infections increases, several companies are vying for market share by developing advanced diagnostic tools and methodologies. The market is distinguished by a variety of testing options including serological tests, breath tests, and biopsy methods, with ongoing research and development fostering the introduction of innovative technologies.

    Players in this market are also focused on maintaining compliance with stringent regulatory standards while enhancing product efficacy, contributing to a competitive atmosphere driven by both established firms and emerging entities.

    BioRad Laboratories has a formidable presence in the UK Helicobacter Pylori Test Market, bolstered by its reputation for quality and reliability in diagnostic testing solutions. With a diverse portfolio that includes a range of serological tests specifically tailored for the detection of Helicobacter Pylori, BioRad Laboratories leverages its strong research and development capabilities to stay ahead in this competitive field. The company benefits from a well-established distribution network and strategic collaborations within the UK healthcare sector, ensuring that its products are readily accessible to healthcare providers.

    Additionally, BioRad Laboratories has invested in robust customer support and educational initiatives, positioning the brand as a leader in innovation and customer engagement in the UK market.

    Abbott Laboratories is another pivotal player in the UK Helicobacter Pylori Test Market, offering a comprehensive suite of diagnostic solutions aimed at addressing this critical health issue. Their key products include non-invasive breath testing and serological diagnostics that have demonstrated high sensitivity and specificity. Abbott Laboratories leverages its extensive research capabilities and market experience to continuously innovate and enhance the accuracy of its testing methodologies. The company has forged strategic alliances and partnerships within the UK to expand its market reach while reinforcing its commitment to providing high-quality healthcare solutions.

    Moreover, Abbott Laboratories has focused on mergers and acquisitions to strengthen its product portfolio and enhance technological capabilities, allowing it to stay competitive and responsive to the evolving healthcare landscape in the UK.

    Key Companies in the UK Helicobacter Pylori Test Market market include

    Industry Developments

    The UK Helicobacter Pylori Test Market has seen significant developments recently, including increased awareness about the consequences of H. pylori infections and a growing emphasis on accurate testing methods. Companies such as BioRad Laboratories, Abbott Laboratories, and Thermo Fisher Scientific are actively involved in advancing their testing technologies, with some introducing innovative solutions tailored for enhanced patient comfort and accuracy. In terms of mergers and acquisitions, there have not been significant publicly known transactions involving the mentioned companies in 2023, maintaining a stable competitive landscape.

    The market valuation for companies like DiaSorin and Laboratory Corporation of America Holdings has experienced growth due to heightened demand for diagnostic solutions, impacting the overall market positively. Over the past few years, particularly between 2021 and 2022, there was a noticeable surge in investment directed toward Research and Development (R&D) for H. pylori tests, contributing to technological advancements within the UK healthcare sector. Regulatory support from government bodies also reflects an encouraging environment for market expansion, as awareness campaigns continue to encourage early testing and treatment of H. pylori-related illnesses.

    Market Segmentation

    Helicobacter Pylori Test Market Type Outlook

    • Non-endoscopic
    • Endoscopic

    Helicobacter Pylori Test Market End User Outlook

    • Hospitals & clinics
    • Diagnostic laboratories
    • Others

    Helicobacter Pylori Test Market Technology Outlook

    • Immunoassays
    • Point of care
    • Molecular Diagnostics

    Report Scope

    Report Attribute/Metric Source: Details
    MARKET SIZE 2018 114.59(USD Million)
    MARKET SIZE 2024 121.12(USD Million)
    MARKET SIZE 2035 435.0(USD Million)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 12.325% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Million
    KEY COMPANIES PROFILED BioRad Laboratories, Abbott Laboratories, Thermo Fisher Scientific, DiaSorin, Cypress Diagnostics, Laboratory Corporation of America Holdings, Genometrics, BD, Sekisui Diagnostics, Meridian Bioscience, MediSense, Quidel Corporation, F. HoffmannLa Roche, Hologic, AccuBioTech
    SEGMENTS COVERED Type, Technology, End User
    KEY MARKET OPPORTUNITIES Increased demand for rapid testing, Growing focus on gastrointestinal health, Expansion of telehealth services, Rising prevalence of related diseases, Technological advancements in diagnostic methods
    KEY MARKET DYNAMICS growing prevalence of infections, increasing awareness and education, advancements in testing technologies, rising healthcare expenditures, government support and policies
    COUNTRIES COVERED UK

    FAQs

    What is the expected market size of the UK Helicobacter Pylori Test Market in 2024?

    The UK Helicobacter Pylori Test Market is expected to be valued at 121.12 million USD in 2024.

    What is the projected market value for the UK Helicobacter Pylori Test Market in 2035?

    By 2035, the UK Helicobacter Pylori Test Market is anticipated to reach a valuation of 435.0 million USD.

    What is the expected compound annual growth rate (CAGR) for the UK Helicobacter Pylori Test Market from 2025 to 2035?

    The market is expected to grow at a CAGR of 12.325% during the period from 2025 to 2035.

    Which type of Helicobacter Pylori test is estimated to dominate the market in 2024?

    In 2024, the non-endoscopic type is estimated to lead the market, valued at 72.67 million USD.

    What is the market value for endoscopic Helicobacter Pylori tests in 2035?

    The market for endoscopic Helicobacter Pylori tests is projected to be valued at 174.0 million USD in 2035.

    Who are the key players in the UK Helicobacter Pylori Test Market?

    Major players in the market include BioRad Laboratories, Abbott Laboratories, and Thermo Fisher Scientific.

    What market opportunities are present for the UK Helicobacter Pylori Test Market?

    Opportunities in the market are driven by increasing prevalence and awareness of Helicobacter Pylori infections.

    What are the key challenges faced by the UK Helicobacter Pylori Test Market?

    Challenges include competition among established players and the need for continuous innovation in testing methods.

    How do growth drivers affect the UK Helicobacter Pylori Test Market?

    Growth drivers include advancements in diagnostic technologies and rising healthcare expenditure in the UK.

    What is the expected market growth rate for non-endoscopic tests between 2025 and 2035?

    The non-endoscopic test segment is expected to significantly contribute to the market growth during this period.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    No regional reports available for this market.

    No country-specific reports available for this market.

    Customer Stories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials

    Global Magnesium Sulfate Market – Forecast till 2027